Announced
Completed
Synopsis
Bpifrance and Omnes, a European investor in private equity and infrastructure, led a $14m Series A round in AlgoTherapeutix, a France-based biotechnology company. “I am thrilled that such high-profile partners as Bpifrance and Omnes decided to support ATX01’s development journey towards a genuine relief for countless patients around the world,” Stephane Thiroloix, AlgoTherapeutix Founder & CEO.
Principals
Show Details & Financials
Sort
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.